| # | Drug | Count |
|---|---|---|
| 0 | GADODIAMIDE | 22 |
| 1 | VIGABATRIN | 17 |
| 2 | OCRELIZUMAB | 15 |
| 3 | PROPRANOLOL HYDROCHLORIDE | 12 |
| 4 | ERGOCALCIFEROL | 11 |
| 5 | LEVETIRACETAM | 11 |
| 6 | LEVETIRACETAM IN SODIUM CHLORIDE | 10 |
| 7 | LEVETIRACETAM INJECTION | 10 |
| 8 | LEVETIRACETAM ORAL | 10 |
| 9 | PALBOCICLIB | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GADODIAMIDE | 22 | 0.0065 |
| 1 | FOSNETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| 2 | NETUPITANT AND PALONOSETRON | 3 | 0.0025 |
| 3 | GADOTERIDOL | 3 | 0.0017 |
| 4 | VIGABATRIN | 17 | 0.0012 |
| 5 | GADOBENATE DIMEGLUMINE | 5 | 0.0011 |
| 6 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 7 | GADOTERATE MEGLUMINE | 3 | 0.0008 |
| 8 | SIROLIMUS | 8 | 0.0006 |
| 9 | PHENOBARBITAL | 8 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Paramagnetic Contrast Agent [EPC] | 22 |
| 1 | Kinase Inhibitor [EPC] | 21 |
| 2 | Anti-epileptic Agent [EPC] | 17 |
| 3 | Benzodiazepine [EPC] | 16 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 6 | Provitamin D2 Compound [EPC] | 11 |
| 7 | Corticosteroid [EPC] | 10 |
| 8 | Estrogen Receptor Antagonist [EPC] | 9 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Paramagnetic Contrast Agent [EPC] | 22 | 0.0048 |
| 1 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 3 | Estrogen Receptor Antagonist [EPC] | 9 | 0.0002 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 7 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |